1. Home
  2. Team
  3. Eric Fritz

Eric joined MVM in 2019. Before joining, he was an engagement manager at McKinsey & Company where he served pharmaceutical and medical device clients on corporate strategy and transactions.

Eric received his PhD in Biological Sciences from Rockefeller University where his thesis research focused on applying genomic techniques to problems in immunology. He also holds an AB summa cum laude in chemistry from Harvard.

Eric is a member of the board of Providence Medical Technology, Inc.

Latest news

Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study
June 4, 2024
GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.
April 15, 2024
Optinose’s XHANCE® Approved by FDA for Chronic Rhinosinusitis without Nasal Polyps
March 15, 2024
GT Medical Technologies Names Per Langoe As CEO
February 20, 2024
MVM invests in icotec
January 24, 2024
MVM invests in Gynesonics
November 1, 2023
SkyCell Featured in TechCrunch
October 31, 2023
MVM invests in BioProtect
September 27, 2023
VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
July 18, 2023
MVM invests in CurvaFix
July 14, 2023
View all